US Patent 11123399 Modulators of complement activity
Patent 11123399 was granted and assigned to Ra Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+292 characters)
Article
Patent abstract
The present disclosure relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics. Also provided are methods of measuring C5 and related complexes using C5 binding agents.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Alonso Ricardo0
Douangsone D. Vadysirisack0
Douglas A. Treco0
Guo-Qing Tang0
Kathleen Seyb0
Michelle Denise Hoarty0
Ramin Farzaneh-Far0
Robert Paul Hammer0
Steven James DeMarco0
Sylvia Tobe0
Vaishnavi Rajagopal0
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11123399 Modulators of complement activity
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11123399
Date of patent
September 21, 2021
Patent application number
20171207
Date Filed
December 7, 2017
Find more entities like US Patent 11123399 Modulators of complement activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
